Combined Screening for Early Detection of Pre-Eclampsia

Park, Hyojin; Shim, Sung Shin; Hyun, Dong Choon

doi:10.3390/ijms160817952

Cited by 60 publications

(34 citation statements)

References 146 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…using the formula described byKatz 2004 and adapted in research work of Park HJ 2015[36] [37]. Serum Caspase 3 levels were quantified by sandwich enzyme immunoassay technique according to the procedure provided in the manual by CUSABIO, USA.…”

mentioning

confidence: 99%

Maternal Serum Biochemical Indicators of Trophoblastic Cell and Endothelial Function at First Trimester of Pregnancy

Gadde¹,

Dayanand²,

Sheela³

2018

OJOG

View full text Add to dashboard Cite

Background: Preeclampsia is a worldwide pregnancy complication, and early identification of patients with an increased risk is one of the key goals in obstetrics. First trimester screening is crucial over the second trimester for understanding the early onset of the disorder, with basal levels of the biochemical parameters associated with the underlying placentation process. Objective: The study aims to assess the levels of serum biochemical markers in pregnant women at first trimester, to evaluate statistical significance and correlation of the values in support of trophoblastic cell integrity, endothelial function and oxidative stress. Materials and Methods: A longitudinal study was conducted on 86 pregnant women of age group 20 -35 years, Primigravida with singleton pregnancy who visited prenatal check up between 11 -13 weeks of gestation. Maternal sera was collected for screening Placental protein 13 (PP13), Caspase 3, Asymmetric dimethylarginine (ADMA), Nitric oxide (NO) by ELISA. Xanthine oxidase (XO) activity was assayed spectrophotometrically. Calcium and Uric acid (UA) were measured by dry chemistry analyser. Results: The mean ± SD values for mean arterial pressure (MAP) are 108.4 ± 18.9, UA 2.01 ± 0.85, Total oxidant status (TOS) 12.83 ± 5.17, Total antioxidant capacity (TAC) 24.

show abstract

mentioning

confidence: 99%

Maternal Serum Biochemical Indicators of Trophoblastic Cell and Endothelial Function at First Trimester of Pregnancy

Gadde¹,

Dayanand²,

Sheela³

2018

OJOG

View full text Add to dashboard Cite

show abstract

“…SBP and DBP were measured in pregnant women using a sphygmomanometer at first and second trimester of pregnancy. MAP was calculated by using the formula described by Katz 2004 which was adapted in research work of Park HJ et al in 2015 [17] [18].…”

Section: Methodsmentioning

confidence: 99%

Relationship between Mean Arterial Pressure, Uric Acid and Calcium with Xanthine Oxidase Activity and Fetal Outcome in Normotensive and Preeclampsia in a Nested Study

Gadde¹,

Doddaiah²,

Rangappa³

2018

OJOG

View full text Add to dashboard Cite

Preeclampsia is a pregnancy complication; early identification with increased risk is one of the key goals in obstetrics. In a nested case control study, serum uric acid and calcium measured in first and second trimesters of pregnancy were correlated with Xanthine oxidase (XO) activity, mean arterial pressure (MAP) and fetal birth weight. The mean ± SD of uric acid (2.01 ± 0.85, 4.8 ± 1.93), calcium (10.88 ± 1.97, 9.72 ± 2.04), MAP (84.32 ± 6.71, 78.40 ± 8.53) and XO activity (11.96 ± 1.91, 14.05 ± 3.09) of the study group (n=86) were observed in the first and second trimesters respectively. First trimester normotensive group (n=79) and preeclampsia cases (n = 7), showed a mean ± SD of uric acid (1.93 ± 0.80, 2.9 ± 0.88), Calcium (10.92 ± 1.9, 10.6 ± 1.72), MAP (84.19 ± 6.75, 85.71 ± 6.58) XO activity (11.82 ± 1.83, 13.57 ± 2.21). In the second trimester, normotensive group and preeclampsia cases showed a mean ± SD uric acid (4.6 ± 1.75, 7.3 ± 2.19), Calcium (9.4 ± 1.85, 12.9 ± 1.04), MAP (76.41 ± 5.41, 100.95 ± 2.52) and XO activity (13.37 ± 1.93, 21.70 ± 3.50). Statistical analysis revealed a non-significant positive correlation in first trimester between uric acid and MAP (r = +0.116, p = 0.288), negative correlations between uric acid and fetal birth weight (r = −0.118, 0.279) and between calcium and MAP (r = −0.288, p = 0.007). In the second trimester, significant positive correlations were observed between uric acid (r = +0.246, p = 0.022), calcium (r = +0.326, p = 0.007) with MAP along with a significant negative correlation between uric acid (r = −0.641, p = 0.000), calcium (r = −0.316, p = 0.003), Proteinuria (r = −0.514, p = 0.000) with fetal birth weight. The screening of first and second trimesters XO activity, uric acid, calcium and MAP during pregnancy is beneficial in identifying women likely to develop

show abstract

“…[9][10][11] Berbagai upaya telah dilakukan untuk menurunkan angka kematian ibu, salah satunya dengan cara melakukan pendeteksian terhadap PE, tetapi pendeteksian PE saat ini masih terbatas, antara lain dengan memeriksa faktor-faktor pada masa kehamilan. 12 Metode tersebut masih tergolong kurang dalam hal mendukung peningkatan survival rate dari pasien PE. Namun dengan perkembangan ilmu pengetahuan dan teknologi yang pesat, penemuan cara deteksi dini merupakan suatu langkah preventif yang efektif dalam menanggulangi masalah kematian ibu yang disebabkan oleh PE-eklampsia.…”

Section: 5unclassified

PlGF/sFlt‑1 as Early Detection Biomarker for Preeclampsia

Sinuraya¹,

Nisa

Lokajaya

et al. 2017

Indones J Clin Pharm

View full text Add to dashboard Cite

AbstrakProgram Millenium Development Goals (MDGs) yang dilakukan sejak tahun 2003 belum berhasil mencapai tujuannya, termasuk untuk meningkatkan kesehatan ibu dengan target menurunkan Angka Kematian Ibu (AKI) sebesar tiga perempatnya antara tahun 1990 sampai 2015. Program ini kemudian dilanjutkan menjadi Sustainable Development Goals (SDGs) dengan salah satu fokusnya yaitu menurunkan AKI hingga di bawah 70 per 100.000 kelahiran hidup serta mengurangi sepertiga kematian bayi prematur akibat penyakit tidak menular. Angka kematian ibu di Indonesia cukup tinggi apabila dibandingkan dengan negara-negara lainnya di wilayah Asia Tenggara. Pada umumnya penyebab utama kematian ibu adalah pendarahan (28%), preeklampsia (PE)/eklampsia (24%), infeksi (11%), komplikasi persalinan (5%) dan abortus (5%). Preeklampsia (PE) merupakan penyakit hipertensi yang disertai dengan proteinuria yang terjadi pada saat usia kehamilan mencapai 20 minggu (trimester kedua). Penyakit ini umumnya tidak terdiagnosis namun terlihat setelah berdampak pada gangguan ibu dan janin dan apabila tidak ditangani dengan segera, maka dapat menyebabkan kematian bagi ibu pada proses persalinan. Dilaporkan bahwa rata-rata insiden kejadia PE di seluruh dunia adalah 2-10%. Berbagai upaya terus dilakukan untuk menurunkan angka kematian Ibu ini, salah satunya adalah dengan pencarian metode deteksi dini. Tujuan penulisan review ini adalah untuk mengkaji metode deteksi dini apa yang paling efektif dan efisien untuk mengatasi PE. Metode dalam review ini adalah penelusuran data berbasis Pubmed, Scopus dan Google Scholar dan tanpa pembatasan index factor dengan menggunakan kata kunci "biomarker, preeclampsia", "early detection, preeclampsia". Hasil review menunjukkan bahwa biomarker placental growth gactor (PlGF) dan soluble Fms-like tyrosine kinase 1 (sFlt-1) merupakan biomarker spesifik dengan sensitivitas dan spesifisitas yang tinggi dalam pendeteksian PE. Kata kunci:Biomarker PlGF/sFlt-1, deteksi dini, preeklampsia PlGF/sFlt-1 as Early Detection Biomarker for Preeclampsia AbstractMillennium Development Goals (MDGs) had been conducted since 2003 with uncomplished outcome target, particularly improving maternal health and lowering maternal mortality until one-fourth of population from 1990 until 2015. Then, this program was continued through Sustainable Development Goals (SDGs) in 2015 with lowering maternal mortality below 70 per 100,000 live births and reducing premature mortality due to one-third because of uncommunicable diseases. Maternal mortality in Indonesia is quite high compared with the other countries in the Southeast Asia. Generally, the main causes of maternal death are haemorrhage (28%), preeclampsia (PE)/eclampsia (24%), infection (11%), complications from birth delivery (5%), and unsafe abortion (5%). Preeclampsia (PE) is a hypertension disease accompanied with proteinuria that occuring in 20 weeks of pregnancy (second trimester). The disease is commonly unvisible and underdiagnosed until clinical manifestations were presented (e.g. maternal and fet...

show abstract

Combined Screening for Early Detection of Pre-Eclampsia

Cited by 60 publications

References 146 publications

Maternal Serum Biochemical Indicators of Trophoblastic Cell and Endothelial Function at First Trimester of Pregnancy

Maternal Serum Biochemical Indicators of Trophoblastic Cell and Endothelial Function at First Trimester of Pregnancy

Relationship between Mean Arterial Pressure, Uric Acid and Calcium with Xanthine Oxidase Activity and Fetal Outcome in Normotensive and Preeclampsia in a Nested Study

PlGF/sFlt‑1 as Early Detection Biomarker for Preeclampsia

Contact Info

Product

Resources

About